In Vitro Activity of the Novel Lactone Ketolide Nafithromycin (WCK 4873) against Contemporary Clinical Bacteria from a Global Surveillance Program

  • R. K. Flamm, P. R. Rhomberg, H. S. Sader
  • Antimicrobial Agents and Chemotherapy, October 2017, ASM Journals
  • DOI: 10.1128/aac.01230-17

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1128/aac.01230-17